Table 2.
Systemic treatment of the first primary cancer | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cytotoxics only |
Cytotoxics and immunotherapy |
Immunotherapy only |
No cytotoxics, no immunotherapy |
All patients |
||||||
n = 16 997 | (%) | n = 1131 | (%) | n = 32 | (%) | n = 28 669 | (%) | N = 46 829 | (%) | |
Age at first cancer | ||||||||||
<30 | 38/1436 | 2.6% | 0/24 | 0.0% | 0/5 | 0.0% | 123/2597 | 4.7% | 161/4062 | 4.0% |
30-60 | 151/6737 | 2.2% | 1/509 | 0.2% | 0/14 | 0.0% | 496/11 717 | 4.2% | 648/18 977 | 3.4% |
>60 | 248/8824 | 2.8% | 5/598 | 0.8% | 1/13 | 7.7% | 767/14 355 | 5.3% | 1021/23 790 | 4.3% |
All | 437/16 997 | 2.6% | 6/1131 | 0.5% | 1/32 | 3.1% | 1386/28 669 | 4.8% | 1830/46 829 | 3.9% |